CAS: 115007-34-6; Mycophenolate Mofetil

上下游产品

CAS号622-40-2 N-(2-羟乙基)吗啉 | CAS号31858-66-9 麦考酚酸甲酯-d6(EP杂质E) | CAS号24280-93-1 霉酚酸 | CAS号66341-85-3 6-(4-hydroxy-6-... | CAS号3647-69-6 N-(2-氯乙基)吗啉盐酸盐 | CAS号111512-13-1 E-6-(1,3-dihydr... | CAS号669077-70-7 6-(4-hydroxy-6-... | CAS号1000853-05-3 6-(4-hydroxy-6-... | CAS号1000853-07-5 6-(4-hydroxy-6-...

专利信息

专利号:WO-2004089946-A1
优先权日:2003-04-07
标题:Microwave synthesis of mycophenolate
发明人：ADHIKARY LAXMI; SURYANARAYAN SHRIKUMAR
权利人:BIOCON LTD; ADHIKARY LAXMI; SURYANARAYAN SHRIKUMAR
摘要:A process for synthesis of a compound of formula (I) using microwave irradiation.

专利号:WO-2024157132-A1
优先权日:2023-01-25
标 题 :Process for the preparation of an intermediate useful for the synthesis of voclosporin
发明人：ROSITANO VINCENZO; MOLINARI MARCO; SENALDI LUCA; ALLEGRINI PIETRO
权利人:INDENA SPA
摘要:The invention relates to a process for the preparation of an intermediate useful for the synthesis of voclosporin, an immunosuppressant active ingredient inhibitor of calcineurin.

专利号:US-2025206743-A1
优先权日:2022-03-25
标 题:Tyk2 inhibitor synthesis and intermediates thereof
发明人：MASSE CRAIG E; PHADKE AVINASH S; LAWSON JON P; LEVY STUART; YANG XIAOWEI; WU GUISHENG; FAN SHUFENG
权利人:TAKEDA PHARMACEUTICALS CO
摘要:Described herein are methods of synthesis of a tyrosine-protein kinase 2 (TYK2) inhibitor and to intermediate compounds of the synthesis and methods of making the intermediates. Also provided are pharmaceutically acceptable compositions including compounds prepared by the synthetic method and methods of treating disorders using the same.

专利号:US-2022356182-A1
优先权日:2009-03-27
标题 :Inhibitors of hepatitis c virus replication
发明人：COBURN CRAIG A; LUDMERER STEVEN W; LIU KUN; WU HAO; SOLL RICHARD; ZHONG BIN; ZHU JIAN
权利人:MERCK SHARP & DOHME
摘要:The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5A inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5A activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.

专利号:US-11649285-B2
优先权日:2016-08-03
标题 :Identification of VSIG3/VISTA as a novel immune checkpoint and use thereof for immunotherapy
发明人：KALABOKIS VASSILIOS; WANG JINGHUA; WU GUOPING; BAZAN JOSE FERNANDO; VALLEY CHRISTOPHER CARLIN
权利人:BIO TECHNE CORP
摘要:The ligand for VISTA is identified (VSIG3) as well as the use of this ligand and receptor interaction in the identification or synthesis of a VSIG3 agonist or antagonist compounds, preferably antibodies, polypeptides and fusion proteins which agonize or antagonize the effects of VSIG3 and/or VISTA and/or the VSIG3/VISTA interaction. These antagonists may be used to suppress VSIG3/VISTA's suppressive effects on T cell immunity, and more particularly used in the treatment of cancer, or infectious disease. These agonist compounds may be used to potentiate or enhance VSIG3/VISTA's suppressive effects on T cell immunity and thereby suppress T cell immunity, such as in the treatment of autoimmunity, allergy or inflammatory conditions. Screening assays for identifying these agonists and antagonist compounds are also provided.

专利号:US-8263755-B2
优先权日:2006-11-20
标题:Synthesis of compounds useful as modulators of amyloid-beta production
发明人：FINDEIS MARK A
权利人:FINDEIS MARK A; SATORI PHARMACEUTICALS INC
摘要:As described herein, the present invention provides methods for preparing compounds useful for treating or lessening the severity of a neurodegenerative disorder. The present invention also provides methods of treating or lessening the severity of such disorders wherein said method comprises administering to a patient a compound of the present invention, or composition thereof. Said method is useful for treating or lessening the severity of, for example, Alzheimer's disease.